MINERVA SURGICAL INC

2022 Q4 Form 10-Q Financial Statement

#000095017022025028 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.942M $15.11M $6.128M
YoY Change -82.9% 146.61%
Cash & Equivalents $6.942M $15.11M $6.128M
Short-Term Investments
Other Short-Term Assets $755.0K $119.0K $170.0K
YoY Change 406.71% -30.0%
Inventory $16.85M $17.00M $14.96M
Prepaid Expenses $2.164M $1.735M $1.794M
Receivables $7.244M $6.791M $6.758M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $36.12M $49.20M $39.87M
YoY Change -51.84% 23.39%
LONG-TERM ASSETS
Property, Plant & Equipment $5.042M $5.031M $3.791M
YoY Change 9.75% 32.71%
Goodwill
YoY Change
Intangibles $37.01M
YoY Change
Long-Term Investments
YoY Change
Other Assets $426.0K $265.0K $524.0K
YoY Change -18.7% -49.43%
Total Long-Term Assets $32.78M $34.61M $41.32M
YoY Change -18.23% -16.24%
TOTAL ASSETS
Total Short-Term Assets $36.12M $49.20M $39.87M
Total Long-Term Assets $32.78M $34.61M $41.32M
Total Assets $68.90M $83.80M $81.19M
YoY Change -40.13% 3.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.804M $2.822M $8.451M
YoY Change -22.73% -66.61%
Accrued Expenses $5.524M $10.38M $11.38M
YoY Change -48.19% -8.73%
Deferred Revenue $339.0K $362.0K $262.0K
YoY Change 64.56% 38.17%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.894M $12.66M
YoY Change 902.12%
Total Short-Term Liabilities $14.28M $23.00M $66.27M
YoY Change -37.4% -65.3%
LONG-TERM LIABILITIES
Long-Term Debt $37.44M $39.27M $18.22M
YoY Change -4.21% 115.51%
Other Long-Term Liabilities $0.00 $0.00 $31.87M
YoY Change -100.0% -100.0%
Total Long-Term Liabilities $37.44M $39.27M $18.22M
YoY Change -4.21% 115.51%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.28M $23.00M $66.27M
Total Long-Term Liabilities $37.44M $39.27M $18.22M
Total Liabilities $51.72M $62.27M $205.3M
YoY Change -27.14% -69.67%
SHAREHOLDERS EQUITY
Retained Earnings -$283.7M -$277.4M -$260.4M
YoY Change 13.68% 6.53%
Common Stock $29.00K $28.00K $3.000K
YoY Change 3.57% 833.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $17.18M $21.54M -$247.4M
YoY Change
Total Liabilities & Shareholders Equity $68.90M $83.80M $81.19M
YoY Change -40.13% 3.22%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Amendment Flag
AmendmentFlag
false
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.165
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y2M12D
dei Entity Central Index Key
EntityCentralIndexKey
0001452965
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40919
dei Entity Registrant Name
EntityRegistrantName
MINERVA SURGICAL, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-3422906
dei Entity Address Address Line1
EntityAddressAddressLine1
4255 Burton Dr.
dei Entity Address City Or Town
EntityAddressCityOrTown
Santa Clara
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95054
dei City Area Code
CityAreaCode
855
dei Local Phone Number
LocalPhoneNumber
646-7874
dei Security12b Title
Security12bTitle
Common Stock, $ 0.001 par value
dei Trading Symbol
TradingSymbol
UTRS
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
28968530
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15112000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
40608000
CY2022Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
8024000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
7283000
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6791000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7292000
CY2022Q3 us-gaap Inventory Net
InventoryNet
17003000
CY2021Q4 us-gaap Inventory Net
InventoryNet
15682000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2265000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4139000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
49195000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
75004000
CY2022Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
265000
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
524000
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
28884000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
34970000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5031000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4594000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
429000
CY2022Q3 us-gaap Assets
Assets
83804000
CY2021Q4 us-gaap Assets
Assets
115092000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2822000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3629000
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4224000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3518000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10384000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10662000
CY2022Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
5000000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
5000000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
565000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
22995000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
22809000
CY2022Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
39271000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
39085000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
9094000
CY2022Q3 us-gaap Liabilities
Liabilities
62266000
CY2021Q4 us-gaap Liabilities
Liabilities
70988000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28968185
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28968185
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28822283
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28822283
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
28000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
28000
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
298922000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
293621000
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
11000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
11000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-277423000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-249556000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
21538000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
44104000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
83804000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
115092000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12588000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12506000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
36490000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
38458000
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5775000
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5373000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
16619000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
15760000
CY2022Q3 us-gaap Gross Profit
GrossProfit
6813000
CY2021Q3 us-gaap Gross Profit
GrossProfit
7133000
us-gaap Gross Profit
GrossProfit
19871000
us-gaap Gross Profit
GrossProfit
22698000
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9723000
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7919000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
28887000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
22883000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6142000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3987000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12706000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18115000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1456000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1367000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3985000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4191000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
17321000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
13273000
us-gaap Operating Expenses
OperatingExpenses
45578000
us-gaap Operating Expenses
OperatingExpenses
45189000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-10508000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6140000
us-gaap Operating Income Loss
OperatingIncomeLoss
-25707000
us-gaap Operating Income Loss
OperatingIncomeLoss
-22491000
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
42000
us-gaap Investment Income Interest
InvestmentIncomeInterest
70000
CY2022Q3 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
0
CY2021Q3 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
1300000
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
0
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
4200000
CY2022Q3 us-gaap Interest Expense
InterestExpense
861000
CY2021Q3 us-gaap Interest Expense
InterestExpense
3611000
us-gaap Interest Expense
InterestExpense
2196000
us-gaap Interest Expense
InterestExpense
10663000
CY2021Q3 utrs Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
23383000
utrs Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
15243000
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-16853000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-16853000
utrs Gain Loss On Extinguishment Of Payroll Protection Program Loan
GainLossOnExtinguishmentOfPayrollProtectionProgramLoan
3036000
CY2022Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-2000
CY2021Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-4000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-34000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-544000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11329000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3225000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-27867000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-32272000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-11329000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-3225000
us-gaap Net Income Loss
NetIncomeLoss
-27867000
us-gaap Net Income Loss
NetIncomeLoss
-32272000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.40
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.40
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.15
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.98
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.98
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-15.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-15.04
CY2022Q3 utrs Weighted Average Shares Used In Computing Net Loss Per Share Basic And Diluted
WeightedAverageSharesUsedInComputingNetLossPerShareBasicAndDiluted
28611045
CY2021Q3 utrs Weighted Average Shares Used In Computing Net Loss Per Share Basic And Diluted
WeightedAverageSharesUsedInComputingNetLossPerShareBasicAndDiluted
2798146
utrs Weighted Average Shares Used In Computing Net Loss Per Share Basic And Diluted
WeightedAverageSharesUsedInComputingNetLossPerShareBasicAndDiluted
28553949
utrs Weighted Average Shares Used In Computing Net Loss Per Share Basic And Diluted
WeightedAverageSharesUsedInComputingNetLossPerShareBasicAndDiluted
2145733
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
44104000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3000
CY2022Q1 utrs Stock Issued During Period Value Vesting Of Early Exercised Stock Options
StockIssuedDuringPeriodValueVestingOfEarlyExercisedStockOptions
39000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1523000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-10925000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
34744000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
18000
CY2022Q2 utrs Stock Issued During Period Value Vesting Of Early Exercised Stock Options
StockIssuedDuringPeriodValueVestingOfEarlyExercisedStockOptions
25000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1676000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-5613000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
30850000
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
13000
CY2022Q3 utrs Stock Issued During Period Value Vesting Of Early Exercised Stock Options
StockIssuedDuringPeriodValueVestingOfEarlyExercisedStockOptions
27000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1977000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-11329000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
21538000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-221811000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
886000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
131000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-14948000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-235742000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
40000
CY2021Q2 utrs Stock Issued During Period Value Vesting Of Early Exercised Stock Options
StockIssuedDuringPeriodValueVestingOfEarlyExercisedStockOptions
15000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4478000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-14099000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-245308000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
37000
CY2021Q3 utrs Stock Issued During Period Value Vesting Of Early Exercised Stock Options
StockIssuedDuringPeriodValueVestingOfEarlyExercisedStockOptions
39000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1075000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-3225000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-247382000
us-gaap Profit Loss
ProfitLoss
-27867000
us-gaap Profit Loss
ProfitLoss
-32272000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
186000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3342000
us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
5395000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-16853000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
8053000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
7948000
utrs Non Cash Lease Expense
NonCashLeaseExpense
465000
utrs Gain On Extinguishment Of Paycheck Protection Program Loan
GainOnExtinguishmentOfPaycheckProtectionProgramLoan
3036000
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
5176000
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
5684000
utrs Change In Fair Value Of Redeemable Convertible Preferred Stock Warrant Liability
ChangeInFairValueOfRedeemableConvertiblePreferredStockWarrantLiability
-535000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-4094000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
780000
us-gaap Derivative Fair Value Hedge Included In Effectiveness Gain Loss
DerivativeFairValueHedgeIncludedInEffectivenessGainLoss
15243000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-10000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-501000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1621000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3610000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6600000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1874000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2461000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-807000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4951000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
90000
utrs Percentage Of Revenue From Contract With Customer Excluding Assessed Tax
PercentageOfRevenueFromContractWithCustomerExcludingAssessedTax
1
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1227000
us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
706000
us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
-30000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-606000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19923000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11306000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
125000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
888000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-125000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-888000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
34000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
963000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
5000000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4966000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
963000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-25014000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-11231000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
48415000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
25166000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
23401000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13935000
CY2022Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
15112000
CY2021Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
6128000
CY2022Q3 us-gaap Restricted Cash
RestrictedCash
8289000
CY2021Q3 us-gaap Restricted Cash
RestrictedCash
7807000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
23401000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13935000
us-gaap Interest Paid Net
InterestPaidNet
1930000
us-gaap Interest Paid Net
InterestPaidNet
1894000
utrs Forgiveness Of Ppa Loan
ForgivenessOfPpaLoan
-3036000
utrs Vesting Of Early Exercised Stock Options
VestingOfEarlyExercisedStockOptions
91000
utrs Vesting Of Early Exercised Stock Options
VestingOfEarlyExercisedStockOptions
54000
utrs Reclassification Of Inventory To Property And Equipment For Customer Usage Agreements
ReclassificationOfInventoryToPropertyAndEquipmentForCustomerUsageAgreements
2289000
utrs Reclassification Of Inventory To Property And Equipment For Customer Usage Agreements
ReclassificationOfInventoryToPropertyAndEquipmentForCustomerUsageAgreements
1934000
utrs Right Of Use Asset Acquired Under Operating Lease
RightOfUseAssetAcquiredUnderOperatingLease
894000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
19404066
us-gaap Net Income Loss
NetIncomeLoss
-27900000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-277400000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15100000
utrs Percentage Of Revenue From Contract With Customer Excluding Assessed Tax
PercentageOfRevenueFromContractWithCustomerExcludingAssessedTax
1
CY2022Q3 utrs Percentage Of Revenue From Contract With Customer Excluding Assessed Tax
PercentageOfRevenueFromContractWithCustomerExcludingAssessedTax
1
CY2021Q3 utrs Percentage Of Revenue From Contract With Customer Excluding Assessed Tax
PercentageOfRevenueFromContractWithCustomerExcludingAssessedTax
1
CY2021Q4 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-6.046
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Although these estimates are based on the Company’s knowledge of current events and actions it may undertake in the future, actual results may ultimately materially differ from these estimates and assumptions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant estimates and assumptions include accounts receivable allowances, inventory allowances, recoverability of long-term assets, including definite-lived intangible assets, revaluation of equity instruments and equity-linked instruments, valuation of common stock, stock-based compensation, contingent consideration liability, valuation of the redeemable convertible preferred stock warrant liability and derivative liabilities, deferred tax assets and related valuation allowances, impact of contingencies and the Company’s incremental borrowing rate used to calculate lease assets</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Concentration of credit risk</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial instruments that potentially subject the Company to concentrations of risk consist principally of cash, cash equivalents and accounts receivable. The Company maintains its cash and cash equivalents balances with established financial institutions and, at times, such balances with any one financial institution may be in excess of the Federal Deposit Insurance Corporation (FDIC) insured limits.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company earns revenue from sale of disposable devices and controllers to customers such as hospitals, ambulatory surgical centers and physician offices. The Company’s accounts receivable are derived from revenue earned from customers. The Company performs ongoing credit evaluations of its customers’ financial condition and generally requires no collateral from its customers. At September 30, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and 2021, and for the periods then ended, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> customer accounted for more than 10.0% of accounts receivable or revenue.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
utrs Number Of Customer Accounted For Accounts Receivable Or Revenue
NumberOfCustomerAccountedForAccountsReceivableOrRevenue
0
utrs Number Of Customer Accounted For Accounts Receivable Or Revenue
NumberOfCustomerAccountedForAccountsReceivableOrRevenue
0
utrs Concentration Of Suppliers
ConcentrationOfSuppliers
<span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Concentration of suppliers </span><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company purchases certain components of its products from a single or small number of suppliers. A change in or loss of these suppliers could cause a delay in filling customer orders and a possible loss of sales, which could adversely affect our results of operations; however, management believes that suitable replacement suppliers could be obtained in such an event.</span></p>
CY2022Q3 utrs Expected Operating Lease Right Of Use Assets
ExpectedOperatingLeaseRightOfUseAssets
900000
CY2022Q3 utrs Expected Operating Lease Liability
ExpectedOperatingLeaseLiability
1200000
CY2022Q3 utrs Expected Derecognized Deferred Rent
ExpectedDerecognizedDeferredRent
300000
CY2022Q3 utrs Percentage Of Revenue Subject To Point In Time Recognition
PercentageOfRevenueSubjectToPointInTimeRecognition
0.999
CY2021Q3 utrs Percentage Of Revenue Subject To Point In Time Recognition
PercentageOfRevenueSubjectToPointInTimeRecognition
0.990
CY2022Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
13042000
CY2021Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
38522000
CY2022Q3 utrs Minimum Percentage Of Sale Extended Warranties On Capital Equipment
MinimumPercentageOfSaleExtendedWarrantiesOnCapitalEquipment
0.001
CY2021Q3 utrs Minimum Percentage Of Sale Extended Warranties On Capital Equipment
MinimumPercentageOfSaleExtendedWarrantiesOnCapitalEquipment
0.010
CY2022Q3 utrs Maximum Percentage Of Total Revenue Derived From Sale Of Single Use Disposable Products
MaximumPercentageOfTotalRevenueDerivedFromSaleOfSingleUseDisposableProducts
0.970
CY2021Q3 utrs Maximum Percentage Of Total Revenue Derived From Sale Of Single Use Disposable Products
MaximumPercentageOfTotalRevenueDerivedFromSaleOfSingleUseDisposableProducts
0.981
utrs Percentage Of Revenue Subject To Point In Time Recognition
PercentageOfRevenueSubjectToPointInTimeRecognition
0.999
utrs Percentage Of Revenue Subject To Point In Time Recognition
PercentageOfRevenueSubjectToPointInTimeRecognition
0.990
utrs Minimum Percentage Of Sale Extended Warranties On Capital Equipment
MinimumPercentageOfSaleExtendedWarrantiesOnCapitalEquipment
0.001
utrs Minimum Percentage Of Sale Extended Warranties On Capital Equipment
MinimumPercentageOfSaleExtendedWarrantiesOnCapitalEquipment
0.010
utrs Maximum Percentage Of Total Revenue Derived From Sale Of Single Use Disposable Products
MaximumPercentageOfTotalRevenueDerivedFromSaleOfSingleUseDisposableProducts
0.980
utrs Maximum Percentage Of Total Revenue Derived From Sale Of Single Use Disposable Products
MaximumPercentageOfTotalRevenueDerivedFromSaleOfSingleUseDisposableProducts
0.968
CY2022Q3 us-gaap Contract With Customer Receivable Allowance For Credit Loss
ContractWithCustomerReceivableAllowanceForCreditLoss
6791000
CY2021Q4 us-gaap Contract With Customer Receivable Allowance For Credit Loss
ContractWithCustomerReceivableAllowanceForCreditLoss
7292000
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
362000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
206000
CY2022Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
13042000
CY2022Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
13042000
CY2022Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
5000000
CY2022Q3 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
5000000
CY2021Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
38522000
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
38522000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
14094000
CY2021Q4 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
14094000
CY2022Q3 us-gaap Cash
Cash
2070000
CY2021Q4 us-gaap Cash
Cash
2086000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15112000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
40608000
CY2022Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
8079000
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
9495000
CY2022Q3 utrs Inventory Component Materials
InventoryComponentMaterials
8924000
CY2021Q4 utrs Inventory Component Materials
InventoryComponentMaterials
6187000
CY2022Q3 us-gaap Inventory Net
InventoryNet
17003000
CY2021Q4 us-gaap Inventory Net
InventoryNet
15682000
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1735000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1264000
CY2022Q3 us-gaap Prepaid Insurance
PrepaidInsurance
411000
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
2726000
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
119000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
149000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2265000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4139000
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15202000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13911000
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10171000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9317000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5031000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4594000
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
600000
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
600000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1900000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1800000
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
48315000
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
19431000
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
28884000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
48264000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
13294000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
34970000
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2000000.0
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2000000.0
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6100000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6100000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
2045000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
5376000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
3693000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
3693000
CY2022Q3 utrs Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
14016000
CY2022Q3 utrs Finite Lived Future Amortization Of Intangible Assets Net
FiniteLivedFutureAmortizationOfIntangibleAssetsNet
28823000
CY2022Q3 us-gaap Accrued Vacation Current And Noncurrent
AccruedVacationCurrentAndNoncurrent
1468000
CY2021Q4 us-gaap Accrued Vacation Current And Noncurrent
AccruedVacationCurrentAndNoncurrent
1469000
CY2022Q3 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
1805000
CY2021Q4 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
1307000
CY2022Q3 utrs Accrued Commissions Current And Noncurrent
AccruedCommissionsCurrentAndNoncurrent
690000
CY2021Q4 utrs Accrued Commissions Current And Noncurrent
AccruedCommissionsCurrentAndNoncurrent
665000
CY2022Q3 utrs Other Accrued Personnel Related Expenses
OtherAccruedPersonnelRelatedExpenses
261000
CY2021Q4 utrs Other Accrued Personnel Related Expenses
OtherAccruedPersonnelRelatedExpenses
77000
CY2022Q3 utrs Accrued Compensation
AccruedCompensation
4224000
CY2021Q4 utrs Accrued Compensation
AccruedCompensation
3518000
CY2022Q3 utrs Accrued Litigation
AccruedLitigation
7420000
CY2021Q4 utrs Accrued Litigation
AccruedLitigation
7203000
CY2022Q3 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
648000
CY2021Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
974000
CY2022Q3 utrs Accrued Sales And Use Taxes
AccruedSalesAndUseTaxes
319000
CY2021Q4 utrs Accrued Sales And Use Taxes
AccruedSalesAndUseTaxes
657000
CY2021Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
277000
CY2022Q3 utrs Accrual For Inventory In Transit
AccrualForInventoryInTransit
253000
CY2021Q4 utrs Accrual For Inventory In Transit
AccrualForInventoryInTransit
119000
CY2022Q3 utrs Accrued Contract Liability
AccruedContractLiability
362000
CY2021Q4 utrs Accrued Contract Liability
AccruedContractLiability
206000
CY2022Q3 utrs Accrued Interest Expense
AccruedInterestExpense
261000
CY2021Q4 utrs Accrued Interest Expense
AccruedInterestExpense
189000
CY2022Q3 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
1121000
CY2021Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
1037000
CY2022Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
10384000
CY2021Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
10662000
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
200000
us-gaap Operating Lease Expense
OperatingLeaseExpense
500000
CY2021Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
200000
us-gaap Operating Lease Expense
OperatingLeaseExpense
600000
us-gaap Operating Lease Cost
OperatingLeaseCost
490000
us-gaap Variable Lease Cost
VariableLeaseCost
186000
us-gaap Lease Cost
LeaseCost
676000
us-gaap Operating Lease Payments
OperatingLeasePayments
631000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
429000
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y8M12D
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.040
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
400000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
600000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
215000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
358000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
573000
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
8000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
565000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
565000
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
846000
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
358000
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1204000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017Q2 utrs Class Of Warrant Or Right To Purchase Of Common Stock Issuance Date
ClassOfWarrantOrRightToPurchaseOfCommonStockIssuanceDate
2017-05-09
CY2017Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
33964
CY2017Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.31
CY2017Q2 utrs Class Of Warrant Or Right Classification
ClassOfWarrantOrRightClassification
Equity
CY2017Q2 us-gaap Warrants And Rights Outstanding Maturity Date
WarrantsAndRightsOutstandingMaturityDate
2027-05-08
CY2019Q3 utrs Class Of Warrant Or Right To Purchase Of Common Stock Issuance Date
ClassOfWarrantOrRightToPurchaseOfCommonStockIssuanceDate
2019-07-19
CY2019Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
43878
CY2019Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.31
CY2019Q3 utrs Class Of Warrant Or Right Classification
ClassOfWarrantOrRightClassification
Equity
CY2019Q3 us-gaap Warrants And Rights Outstanding Maturity Date
WarrantsAndRightsOutstandingMaturityDate
2029-07-18
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
77842
CY2022Q3 utrs Warrants To Purchase Common Stock
WarrantsToPurchaseCommonStock
77842
CY2021Q4 utrs Warrants To Purchase Common Stock
WarrantsToPurchaseCommonStock
77842
CY2022Q3 utrs Common Stock Options Issued And Outstanding
CommonStockOptionsIssuedAndOutstanding
2183311
CY2021Q4 utrs Common Stock Options Issued And Outstanding
CommonStockOptionsIssuedAndOutstanding
2175685
CY2022Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
472104
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
1934095
CY2022Q3 utrs Restricted Stock Units Issued And Outstanding
RestrictedStockUnitsIssuedAndOutstanding
1703213
CY2021Q4 utrs Restricted Stock Units Issued And Outstanding
RestrictedStockUnitsIssuedAndOutstanding
394750
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1977000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1075000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5176000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2175685
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.27
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y8M12D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2856000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
189800
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.27
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
56964
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.61
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
125210
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
8.71
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2183311
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.00
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y1M6D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
99000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1577934
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
9.66
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y9M18D
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
81000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2183311
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
9.00
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y1M6D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
99000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2900000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
5100000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.11
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.07
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
5900000
utrs Repurchase Of Common Stock
RepurchaseOfCommonStock
0
utrs Repurchase Of Common Stock
RepurchaseOfCommonStock
0
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
227507
CY2021 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
377709
utrs Share Based Compensation Arrangements By Share Based Payment Award Options Aggregate Exercise Prices Of Early Exercised Shares
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAggregateExercisePricesOfEarlyExercisedShares
100000
CY2021 utrs Share Based Compensation Arrangements By Share Based Payment Award Options Aggregate Exercise Prices Of Early Exercised Shares
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAggregateExercisePricesOfEarlyExercisedShares
200000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5684000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1977000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1075000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5176000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5684000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7220
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.733
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.750
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.708
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.722
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.729
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.759
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.028
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.009
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.011
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.019
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.030
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.006
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.011
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-11329000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-3225000
us-gaap Net Income Loss
NetIncomeLoss
-27867000
us-gaap Net Income Loss
NetIncomeLoss
-32272000
CY2022Q3 utrs Weighted Average Shares Used In Computing Net Loss Per Share Basic And Diluted
WeightedAverageSharesUsedInComputingNetLossPerShareBasicAndDiluted
28611045
CY2021Q3 utrs Weighted Average Shares Used In Computing Net Loss Per Share Basic And Diluted
WeightedAverageSharesUsedInComputingNetLossPerShareBasicAndDiluted
2798146
utrs Weighted Average Shares Used In Computing Net Loss Per Share Basic And Diluted
WeightedAverageSharesUsedInComputingNetLossPerShareBasicAndDiluted
28553949
utrs Weighted Average Shares Used In Computing Net Loss Per Share Basic And Diluted
WeightedAverageSharesUsedInComputingNetLossPerShareBasicAndDiluted
2145733
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.40
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.40
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.15
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.98
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.98
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-15.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-15.04

Files In Submission

Name View Source Status
0000950170-22-025028-index-headers.html Edgar Link pending
0000950170-22-025028-index.html Edgar Link pending
0000950170-22-025028.txt Edgar Link pending
0000950170-22-025028-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
utrs-20220930.htm Edgar Link pending
utrs-20220930.xsd Edgar Link pending
utrs-ex31_1.htm Edgar Link pending
utrs-ex31_2.htm Edgar Link pending
utrs-ex32_1.htm Edgar Link pending
utrs-ex32_2.htm Edgar Link pending
utrs-20220930_def.xml Edgar Link unprocessable
utrs-20220930_lab.xml Edgar Link unprocessable
utrs-20220930_pre.xml Edgar Link unprocessable
utrs-20220930_htm.xml Edgar Link completed
utrs-20220930_cal.xml Edgar Link unprocessable